Is Privi Speciality Chemicals a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Privi Speciality Chemicals Ltd is a average quality company .

Is Privi Speciality Chemicals undervalued or overvalued?

The key valuation ratios of Privi Speciality Chemicals Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Privi Speciality Chemicals share price return in the past 10 years?

Privi Speciality Chemicals Ltd share price has appreciated 18.6% annually (CAGR) over the past ten years.

Is Privi Speciality Chemicals a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Privi Speciality Chemicals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Privi Speciality Chemicals?

The latest standalone P/E ratio of Privi Speciality Chemicals as of 09-Jan-2025 is 49.90.

What is the P/B ratio of Privi Speciality Chemicals?

The latest standalone P/B ratio of Privi Speciality Chemicals as of 09-Jan-2025 is 7.31.

Privi Speciality Chemicals Ltd - Stock Valuation and Financial Performance

Name: Privi Speciality Chemicals
Brand: Privi Speciality Chemicals

BSE: 530117 | NSE: PRIVISCL | Chemicals | Small Cap

Place order

Privi Speciality Che Share Price

₹1,853.75 -12.05 -0.65%
as on 09-Jan'25 16:59

10 Year X-Ray of Privi Speciality Che:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	29%	22.4%	17.2%	22.2%	22.4%	36.2%	15.7%	11.1%	5.6%	12.5%	-
Value Creation Index ⓘ	1.1	0.6	0.2	0.6	0.6	1.6	0.1	-0.2	-0.6	-0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	151	152	185	236	250	1,295	1,255	1,391	1,578	1,712	1,836
Sales YoY Gr.	-	0.7%	22.2%	27.5%	5.7%	418.1%	-3.1%	10.9%	13.4%	8.5%	-
Adj EPS ⓘ	9.6	7.9	2.4	5.2	5.6	26.1	22.5	19.8	2.6	21.7	37.2
YoY Gr.	-	-18.2%	-69.3%	113.6%	8.1%	367.1%	-13.9%	-12%	-86.9%	735.8%	-
BVPS (₹) ⓘ	41.2	45.9	18.8	22.8	26.3	154.3	182.8	206.7	210.6	235.6	253.7
Adj Net Profit ⓘ	13.3	10.9	9.1	19.5	21.8	102	87.9	77.3	10.2	84.9	145
Cash Flow from Ops. ⓘ	32.1	15.7	3.8	15.5	34.2	216	152	14.8	54.7	362	-
Debt/CF from Ops. ⓘ	0.9	2.1	15.4	4.2	1.7	2.2	3.4	59.5	18.7	2.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	31%	47%	10.9%	8.5%
Adj EPS ⓘ	9.5%	31.2%	-1.1%	735.8%
BVPSⓘ	21.4%	55.1%	8.8%	11.9%
Share Price	18.6%	31.7%	-3.9%	63.9%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	25.5	18.1	13.5	24.4	23	28.9	13.3	10.2	1.3	9.7	15.2
Op. Profit Mgn % ⓘ	16.6	15.4	12.8	14.3	14.6	16.6	16.5	14.1	11.6	19.2	21.4
Net Profit Mgn % ⓘ	8.8	7.2	4.9	8.2	8.7	7.9	7	5.6	0.6	5	7.9
Debt to Equity ⓘ	0.5	0.5	0.8	0.8	0.6	0.8	0.7	1.1	1.3	1	0.3
Working Cap Days ⓘ	88	78	83	95	103	100	198	228	256	243	96
Cash Conv. Cycle ⓘ	64	56	61	71	78	55	100	114	149	141	19

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 15.20%

Sales growth is growing at healthy rate in last 3 years 10.90%

Debt to equity has declined versus last 3 years average to 0.96

Sales growth is good in last 4 quarters at 12.15%

Net Profit has been subdued in last 3 years -1.14%

Latest Financials - Privi Speciality Chemicals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	37.2	34.8
TTM Sales (₹ Cr.)	1,836	1,885
BVPS (₹.) ⓘ	253.7	254.1
Reserves (₹ Cr.) ⓘ	960	953
P/BV ⓘ	7.31	7.30
PE ⓘ	49.90	53.32

From the Market
52 Week Low / High (₹)	975.00 / 2030.00
All Time Low / High (₹)	1.24 / 2268.00
Market Cap (₹ Cr.)	7,241
Equity (₹ Cr.)	39.1
Face Value (₹)	10
Industry PE ⓘ	57.1

Management X-Ray of Privi Speciality Che:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Privi Speciality Che

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Privi Speciality Che

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	151	152	185	236	250	1,295	1,255	1,391	1,578	1,712
Operating Expenses ⓘ	126	129	162	203	214	1,080	1,048	1,195	1,395	1,383
Manufacturing Costs	16	17	19	23	26	146	158	192	248	237
Material Costs	97	98	122	157	163	775	726	805	928	961
Employee Cost	7	8	11	13	15	60	63	68	72	65
Other Costs ⓘ	5	6	10	9	9	100	101	129	146	120
Operating Profit ⓘ	25	23	24	34	36	215	207	197	183	329
Operating Profit Margin (%)	16.6%	14.9%	12.8%	14.3%	14.4%	16.6%	16.5%	14.1%	11.6%	19.2%
Other Income ⓘ	1	1	0	3	4	26	20	33	22	22
Interest ⓘ	3	4	5	6	6	37	23	25	68	97
Depreciation ⓘ	2	3	4	5	5	55	69	73	105	122
Exceptional Items ⓘ	0	0	0	0	0	40	23	5	0	0
Profit Before Tax ⓘ	21	17	15	26	29	189	158	137	31	132
Tax ⓘ	7	6	6	6	8	45	41	35	9	34
Profit After Tax	14	11	9	19	22	144	117	102	22	98
PAT Margin (%)	9.1%	7.0%	4.9%	8.2%	8.6%	11.1%	9.3%	7.3%	1.4%	5.7%
Adjusted EPS (₹)	9.9	7.7	2.4	5.2	5.5	36.9	30.0	26.0	5.8	25.1
Dividend Payout Ratio (%)	25%	33%	42%	29%	45%	4%	7%	8%	0%	8%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	57	63	72	87	103	603	714	807	822	920
Share Capital ⓘ	14	14	39	39	39	39	39	39	39	39
Reserves ⓘ	43	49	33	48	64	564	675	768	783	881
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	26	29	50	55	49	462	474	816	922	747
Long Term Debt	14	12	19	16	8	226	332	381	404	384
Short Term Debt	12	17	32	39	40	237	142	435	518	364
Trade Payables	5	3	6	7	10	157	180	308	298	283
Others Liabilities ⓘ	18	20	25	27	27	142	154	197	301	238
Total Liabilities ⓘ	105	114	154	176	188	1,364	1,522	2,128	2,343	2,189
Fixed Assets
Gross Block	88	102	98	111	130	851	921	1,093	1,513	1,649
Accumulated Depreciation	26	29	4	9	14	287	356	427	532	650
Net Fixed Assetsⓘ	62	73	94	102	115	564	565	666	982	999
CWIP ⓘ	8	5	3	3	1	30	174	370	93	27
Investmentsⓘ	0	0	0	0	0	43	43	51	51	62
Inventories	13	13	23	30	34	308	315	561	745	603
Trade Receivables	17	17	25	32	32	217	236	284	314	361
Cash Equivalents	0	0	0	0	0	85	15	31	14	20
Others Assetsⓘ	5	5	8	9	6	117	173	166	143	117
Total Assets ⓘ	105	114	154	176	188	1,364	1,522	2,128	2,343	2,189

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	32	16	4	15	34	216	152	15	55	362
PBT ⓘ	21	17	15	26	29	189	158	137	31	132
Adjustment ⓘ	5	8	9	8	8	76	103	97	181	210
Changes in Working Capital ⓘ	12	-5	-15	-13	1	15	-70	-187	-145	46
Tax Paid ⓘ	-5	-3	-5	-5	-5	-65	-39	-32	-13	-26
Cash Flow From Investing Activity ⓘ	-25	-13	-20	-13	-14	-174	-242	-324	-141	-118
Capex	-26	-13	-20	-15	-17	-170	-242	-316	-142	-103
Net Investments	0	0	0	0	0	-4	0	0	1	0
Others ⓘ	0	0	0	3	4	1	0	-7	0	-15
Cash Flow From Financing Activityⓘ	-7	-3	17	-3	-21	29	19	324	70	-239
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	7	0	11	-1	-10	56	120	76	64	14
Interest Paid ⓘ	-3	-4	-5	-6	-6	-35	-22	-34	-65	-92
Dividend Paid ⓘ	-2	-3	-4	-4	-6	0	-6	-8	-8	0
Others ⓘ	-9	4	15	7	2	8	-73	290	78	-161
Net Cash Flow ⓘ	0	0	0	0	0	72	-71	15	-16	5

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	26.3	17.66	13.54	24.8	22.83	40.83	17.77	13.37	2.76	11.23
ROCE (%)	28.96	22.44	17.15	22.24	22.38	36.24	15.65	11.12	5.63	12.52
Asset Turnover Ratio	1.7	1.52	1.52	1.48	1.38	1.67	0.87	0.76	0.71	0.76
PAT to CFO Conversion(x)	2.29	1.45	0.44	0.79	1.55	1.5	1.3	0.15	2.5	3.69
Working Capital Days
Receivable Days	43	38	38	43	47	35	66	68	69	72
Inventory Days	32	29	33	40	47	48	90	115	151	144
Payable Days	14	14	13	16	19	39	85	111	119	110

Privi Speciality Chemicals Ltd Stock News

Privi Speciality Chemicals Ltd FAQs

What is the share price of Privi Speciality Che?

Company share prices are keep on changing according to the market conditions. The closing price of Privi Speciality Che on 09-Jan-2025 16:59 is ₹1,853.8.

What is the market cap of Privi Speciality Che?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Jan-2025 16:59 the market cap of Privi Speciality Che stood at ₹7,241.3.

What is the P/E ratio of Privi Speciality Che?

The latest P/E ratio of Privi Speciality Che as of 09-Jan-2025 16:59 is 49.90.

What is the P/B ratio of Privi Speciality Che?

The latest P/B ratio of Privi Speciality Che as of 09-Jan-2025 16:59 is 7.31.

What is the 52-week high and low of Privi Speciality Che?

The 52-week high of Privi Speciality Che is ₹2,030 and the 52-week low is ₹975.0.

What is the TTM revenue of Privi Speciality Che?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Privi Speciality Che is ₹1,836 ( Cr.) .

About Privi Speciality Chemicals Ltd

H. K. Finechem is a manufacturing company located near the city of Ahmedabad in the western region of India. Their company utilizes state of the art technology with critical equipments acquired from Germany and Switzerland. Fractions of natural oils and fats such as soyabean, sunflower and cottonseed are the source of the company's fine chemical products. They specialize in oleo chemicals and products for the nutraceutical industry. Their hallmark has been consistent supply of products of superior quality in India, USA, Europe and Japan.

H. K. Finechem is a technology driven company. It has faced the challenges successfully to commercialize products which would help customers in increasing efficiency, reducing cost and minimizing environmental impact.

Their products are manufactured and marketed in a safe and socially acceptable manner by meeting legal obligations.

The company continuously strive to improve quality which is achieved with the help of a sophisticated laboratory having the latest analytical equipments manned by experienced and dedicated personnel. It successfully manufactures quality products developed in-house for the first time in India using high vacuum technology in our modern manufacturing facility.

Product range of the company includes:

The Company's principal activity is to manufacture speciality oleo chemicals and products for the nutraceutical industry. The Company's main products are mixed tocopherols, sterols, linoleic acid, monobasic acid and dimer acid for polyamides and printing ink industry. It processes both the by product streams of vegetable oil refineries viz. vegetable oil based fatty acid distillate and acid oil.

OLEO Chemicals